Zhanjiang Hou1, Chunlei Nie2, Zhenxing Si1, Yongsheng Ma3. 1. Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. 2. Department of Head and Neck Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China. 3. Department of Orthopedic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: yongshenma@163.com.
Abstract
AIMS: Hypoxia-inducible factor (HIF)-1α plays a pivotal role during the process of wound healing. Previous studies reported that deferoxamine (DFO) could increase HIF-1α stability. This study aimed to investigate the effects of DFO on wound healing in diabetic rats and explore the underlying mechanism both in vivo and in vitro. METHODS: An excisional diabetic wound model was established and the wound healing among vehicle control, DFO and vascular endothelial growth factor (VEGF) treatment groups was evaluated by macroscopy, histology and Western blot analysis. Human umbilical vein endothelial cells (HUVECs) were treated with DFO or HIF-1α siRNA, and then endothelial tube formation, cell proliferation and migration were examined. RESULTS: DFO-treated wounds exhibited accelerated wound healing with enhanced granulation formation and increased re-epithelialization. Compared to the vehicle or VEGF treatment, DFO significantly increased neovascularization through up-regulation of HIF-1α and target genes including VEGF and stromal cell-derived factor-1α (SDF-1α). DFO failed to stimulate the expression of VEGF and SDF-1α in HUVECs depleted of HIF-1α. In addition, DFO promoted the angiogenic-associated processes of endothelial tube formation, cell proliferation and migration in HIF-1α dependent manner. CONCLUSIONS: DFO enhances neovascularization and accelerates diabetic wound healing through the accumulation of HIF-1α and the regulation of endothelial cell function. Crown
AIMS: Hypoxia-inducible factor (HIF)-1α plays a pivotal role during the process of wound healing. Previous studies reported that deferoxamine (DFO) could increase HIF-1α stability. This study aimed to investigate the effects of DFO on wound healing in diabeticrats and explore the underlying mechanism both in vivo and in vitro. METHODS: An excisional diabetic wound model was established and the wound healing among vehicle control, DFO and vascular endothelial growth factor (VEGF) treatment groups was evaluated by macroscopy, histology and Western blot analysis. Human umbilical vein endothelial cells (HUVECs) were treated with DFO or HIF-1α siRNA, and then endothelial tube formation, cell proliferation and migration were examined. RESULTS:DFO-treated wounds exhibited accelerated wound healing with enhanced granulation formation and increased re-epithelialization. Compared to the vehicle or VEGF treatment, DFO significantly increased neovascularization through up-regulation of HIF-1α and target genes including VEGF and stromal cell-derived factor-1α (SDF-1α). DFO failed to stimulate the expression of VEGF and SDF-1α in HUVECs depleted of HIF-1α. In addition, DFO promoted the angiogenic-associated processes of endothelial tube formation, cell proliferation and migration in HIF-1α dependent manner. CONCLUSIONS:DFO enhances neovascularization and accelerates diabetic wound healing through the accumulation of HIF-1α and the regulation of endothelial cell function. Crown
Authors: Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker Journal: Adv Drug Deliv Rev Date: 2018-09-26 Impact factor: 15.470
Authors: Yvonn Heun; Kristin Pogoda; Martina Anton; Joachim Pircher; Alexander Pfeifer; Markus Woernle; Andrea Ribeiro; Petra Kameritsch; Olga Mykhaylyk; Christian Plank; Florian Kroetz; Ulrich Pohl; Hanna Mannell Journal: Mol Ther Date: 2017-04-20 Impact factor: 11.454
Authors: M Mehrabani; M Najafi; T Kamarul; K Mansouri; M Iranpour; M H Nematollahi; M Ghazi-Khansari; A M Sharifi Journal: Cell Prolif Date: 2015-10 Impact factor: 6.831
Authors: Swathi Balaji; Maria LeSaint; Sukanta S Bhattacharya; Chad Moles; Yashu Dhamija; Mykia Kidd; Louis D Le; Alice King; Aimen Shaaban; Timothy M Crombleholme; Paul Bollyky; Sundeep G Keswani Journal: J Surg Res Date: 2014-03-02 Impact factor: 2.192
Authors: Swathi Balaji; Nate Han; Chad Moles; Aimen F Shaaban; Paul L Bollyky; Timothy M Crombleholme; Sundeep G Keswani Journal: Surgery Date: 2015-09 Impact factor: 3.982